Precise Biometrics AB Stocks

SEK 1.7Last Updated 17.04.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

SEK 14.19M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SEK 1.7
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Precise Biometrics AB (publ) offers identification software for the secure authentication of people's identity in Europe, Asia, and the United States. It provides Precise YOUNiQ that verifies digital identity; Precise BioMatch Card, a fingerprint algorithm solution for identity authentication in smart cards; Precise BioMatch Mobile, a fingerprint algorithm solution for identity authentication in smartphones and tablets; and Precise BioLive, a fingerprint software that identifies a fake fingerprint. The company offers its products to sensor manufacturers, security companies, and system integrators, as well as finance, betting, healthcare, and transport sectors. Precise Biometrics AB (publ) was incorporated in 1997 and is headquartered in Lund, Sweden.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks